**Question:** 12.6 m old baby was brought c/o difficulty in feeding. The child was found to be hypotonic with a weak gag. The child is on breast milk and mother also gives honey to the child during periods of excessive crying. The causative agent is –

A. Botulinum toxin
B. Botulinum toxin type A
C. Botulinum toxin type B
D. Botulinum toxin type C

**Correct Answer:** **B. Botulinum toxin type A**

**Core Concept:** Botulinum toxin is a potent neurotoxin produced by the bacterium Clostridium botulinum. It acts by inhibiting the release of acetylcholine at neuromuscular junctions, leading to flaccidity and muscle weakness.

**Why the Correct Answer is Right:** Botulinum toxin type A is the most common type to cause infant botulism, a rare but severe illness affecting infants. The toxin is typically ingested through contaminated food, like honey. In this case, the mother giving honey to the child during periods of excessive crying is a risk factor for exposure to the toxin.

**Why Each Wrong Option is Incorrect:**

A. Botulinum toxin types B, C, and D are less common causes of infant botulism. They do not accurately represent the toxin responsible for the described case.

B. Although botulinum toxin type A is associated with infant botulism, the other options (types B, C, and D) are not correctly identified as the causative agent in this scenario.

C. Similar to option A, botulinum toxin types B, C, and D are not the correct toxin implicated in infant botulism.

D. Botulinum toxin type C is not the correct toxin causing infant botulism in this context.

**Clinical Pearls:**

1. Infant botulism is a rare but serious illness in infants caused by the ingestion of Clostridium botulinum spores from contaminated food, particularly honey.
2. Botulinum toxin type A is the most common cause of infant botulism, whereas types B, C, and D are less common.
3. The clinical presentation includes difficulty with feeding, weak sucking reflex, hypotonia, and respiratory distress, which is consistent with the effects of botulinum toxin on neuromuscular transmission.
4. Early recognition and management are crucial to prevent severe complications and ensure a favorable prognosis. Treatment includes supportive care, gastric feeding, and administration of botulinum antitoxin.
5. Botulinum toxin is a potent neurotoxin that blocks acetylcholine release at neuromuscular junctions, causing flaccidity and muscle weakness. In infants, this can lead to difficulty with feeding and swallowing, as well as respiratory distress, which were observed in the case scenario.